MAL2 and pancreatic neoplasm: These findings reveal the potential of MAL2 for serving as a prognostic biomarker for bladder cancer, which is supported by the findings from previous studies on the association between MAL2 and prognostic conditions of breast, colorectal, and pancreatic cancers.34, 36, 37